nulibry
tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
methylphenidate sandoz forðatafla 54 mg
sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 54 mg
nicorette cooldrops hörð munnsogstafla 2 mg
mcneil denmark aps - nicotinum resin-komplex - hörð munnsogstafla - 2 mg
methylphenidate sandoz forðatafla 27 mg
sandoz a/s - methylphenidatum hýdróklóríð - forðatafla - 27 mg
dronedarone stada (verodron) filmuhúðuð tafla 400 mg
stada arzneimittel ag - dronedaronum hýdróklóríð - filmuhúðuð tafla - 400 mg
methylphenidate sandoz forðatafla 18 mg
sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 18 mg
methylphenidate sandoz forðatafla 36 mg
sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 36 mg
nicorette cooldrops hörð munnsogstafla 4 mg
mcneil denmark aps - nicotinum resin-komplex - hörð munnsogstafla - 4 mg
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).